Johnson Swot Analysis Essay

This SWOT analysis focuses on Johnson & Johnson, the world’s most comprehensive and broadly based healthcare product manufacturer with more than 200 operating companies. In 1886, three brothers, Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson, found the company in New Brunswick, New Jersey. The company has a portfolio of subsidiaries that made medical devices, medical diagnostic equipment, biologics, pharmaceuticals as well as healthcare products. Johnson & Johnson is involved with numerous causes and advertising campaigns, which encourage healthy lifestyles, and support those people who care for the health of others. Johnson & Johnson is one of the worlds most admired and trusted companies. There is an increasing pressure

There is an increasing pressure within pharmaceutical markets to reduce prices in line with medical budgets, as well as maintaining patent expirations. Being a global brand means disturbance in the operations when the market fluctuates. There is an internal weakness in the pharmaceutical industry, which includes theft and counterfeiting of drugs, and therefore is a weakness of Johnson & Johnson. While Johnson & Johnson has these specified weaknesses they deal with, there are even more opportunities which gives them an advantage for strengthening their position in the market. They already have the strength of meeting a broader range of customer needs with their products falling under three categories. Expiring patents on brand name drugs lead to an increase in the sales of generic drugs, Johnson & Johnson could capitalize upon this opportunity. With diagnostic markets growing, this positions the company in a good place as well as new medical therapies and findings that align with some of the company’s primary capabilities. Threats the company faces is with product recalls, extreme competition in pharmaceuticals that results usually in the first to enter is generally where success is determined. With technology developments, biotech concepts might possibly move the traditional pharmaceutical methods out of the